LeventMutluMD

PubMed

• Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
  Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman, Levent Mutlu, Cem Demirkiran, Tobias Max Philipp Hartwich, Ya...> ;Proceedings of the National Academy of Sciences of the United States of America. 2024 Apr 23
• Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
  Sangini S Sheth, Ji Eun Oh, Stefania Bellone, Eric R Siegel, Michelle Greenman, Levent Mutlu, Blair McNamara, Shefali Pathy, Mitchell Clark, Masoud Azodi, Gary Altwerg...> ;Clinical Cancer Research. 2024 Apr 9
• Targeting cervical cancer with anti-PD-1 antibodies: what is new?
  Michelle Greenman, Blair McNamara, Levent Mutlu, Alessandro D Santin> ;Expert Opinion on Biological Therapy. 2024 Mar 1
• Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer.
  Cem Demirkiran, Tobias Max Philipp Hartwich, Stefania Bellone, Diego Manavella, Michelle Greenman, Margherita Zipponi, Yang Yang-Hartwich, Kevin Yang, Silvia Coma, Jon...> ;Gynecologic Oncology. 2024 Feb 9
• Antibody-Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors.
  Blair McNamara, Michelle Greenman, Nicole Pebley, Levent Mutlu, Alessandro D Santin> ;Molecules. 2023 Nov 2
• HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma.
  Blair McNamara, Levent Mutlu, Michelle Greenman, Justin Harold, Alessandro Santin> ;Cancers. 2023 Aug 14
• 3 citations
  Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
  Julia H Gelissen, Naomi N Adjei, Blair McNamara, Levent Mutlu, Justin A Harold, Mitchell Clark, Gary Altwerger, Peter R Dottino, Gloria S Huang, Alessandro D Santin, M...> ;Annals of Surgical Oncology. 2023 Sep 1
• 2 citations
  Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers.
  Stefania Bellone, Blair McNamara, Levent Mutlu, Cem Demirkiran, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Eric R Siegel, Alessandro D Santin> ;International Journal of Molecular Sciences. 2023 May 17
• 1 citations
  Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
  Manavella, D., Blair McNamara, Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem...> ;Gynecologic Oncology. 2023 May 1
• 8 citations
  Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian car...
  Manavella, D., Dennis Mauricio, Stefania Bellone, Levent Mutlu, Blair McNamara, Diego D Manavella, Cem Demirkiran, Miguel Skyler Z Verzosa, Natalia Buza, Pei Hui, Tobi...> ;Gynecologic Oncology. 2023 Mar 1
• 4 citations
  Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma".
  Justin Harold, Stefania Bellone, Diego D Manavell, Levent Mutlu, Blair McNamara, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, M...> ;Gynecologic Oncology. 2023 Mar 1
• 1 citations
  Pembrolizumab with chemotherapy, with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer.
  Blair McNamara, Yifan Chang, Levent Mutlu, Justin Harold, Alessandro D Santin> ;Expert Opinion on Biological Therapy. 2023 Mar 1
• 2 citations
  Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
  Manavella, D., Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Levent Mutlu, Margherita Zipponi, C...> ;Gynecologic Oncology. 2023 Feb 1
• The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitr...
  Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Philipp Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demi...> ;Gynecologic Oncology. 2023 Mar 1
• 23 citations
  Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes.
  Levent Mutlu, Giuseppe Gullo, Blair McNamara, Alessandro D Santin, Pasquale Patrizio, Manavella, D., Diego D Manavella> ;Cancers. 2022 Oct 22
• 6 citations
  Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
  Manavella, D., Ghanshyam Yadav, Dana M Roque, Stefania Bellone, Diego D Manavella, Tobias M P Hartwich, Margherita Zipponi, Justin Harold, Joan Tymon-Rosario, Levent M...> ;Gynecologic Oncology. 2022 Aug 1
• 12 citations
  Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine dip...
  Manavella, D., Joan R Tymon-Rosario, Paola Manara, Diego D Manavella, Stefania Bellone, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipp...> ;Gynecologic Oncology. 2022 Jul 1
• 8 citations
  Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer.
  Levent Mutlu, Joan Tymon-Rosario, Justin Harold, Gulden Menderes> ;Expert Review of Anticancer Therapy. 2022 Jun 1
• Therapeutic role of uterine-derived stem cells in acute kidney injury.
  Ramanaiah Mamillapalli, SiHyun Cho, Levent Mutlu, Hugh S Taylor> ;Stem Cell Research & Therapy. 2022 Mar 12
• 7 citations
  Immune checkpoint inhibitors for recurrent endometrial cancer.
  Levent Mutlu, Justin Harold, Joan Tymon-Rosario, Alessandro D Santin> ;Expert Review of Anticancer Therapy. 2022 Mar 1
• 1 citations
  Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites.
  Jessie Y Li, Levent Mutlu, Joan Tymon-Rosario, Wafa Khadraoui, Nupur Nagarkatti, Pei Hui, Natalia Buza, Lingeng Lu, Peter Schwartz, Gulden Menderes> ;Gynecologic Oncology Reports. 2022 Feb 1
• 2 citations
  Characterization of Bone Marrow Progenitor Cell Uterine Engraftment and Transdifferentiation
  Ramanaiah Mamillapalli, Levent Mutlu, Hugh S. Taylor> ;Reproductive Sciences. 2021 Sep 13
• 1 citations
  Laparoscopic Colpo-Pneumo Occluder As A Vaginal Mold For Vaginal Reconstruction
  Alla Vash-Margita, Levent Mutlu, Oz Harmanli> ;Journal of Pediatric and Adolescent Gynecology. 2021 Feb 1
• Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
  Wafa Khadraoui, Christina Tierney, Sophie H. Chung, Levent Mutlu, Lingeng Lu, Masoud Azodi, Elena Ratner, Gulden Menderes> ;International Journal of Gynaecology and Obstetrics. 2020 Sep 1
• 2 citations
  Robotic Colostomy Takedown in a Patient with Extensive Ventral Hernias and Adhesive Disease.
  Levent Mutlu, S Kim, Gary Altwerger, Gulden Menderes> ;Journal of Minimally Invasive Gynecology. 2020 Jan 1
• Join now to see all